Vaccine Choice Canada Mumps - Disease & Vaccine Information

Mumps

The most prominent symptom of mumps is swelling of the saliva glands in the cheeks. Up to 30% of individuals infected with mumps will have no symptoms, and up to 50% exhibit signs of a mild nonspecific illness such as fever, fatigue and head and body ache. [38] Mumps is a mild disease in healthy children. The symptoms tend to be more severe in adults which is the reason it is better to experience mumps in childhood. Most people recover from mumps infection in two weeks. No treatment is necessary beyond alleviating symptoms and rest.

The Vaccine

The mumps vaccine is a live-virus vaccine grown in cultures of chicken embryo cells.
The mumps vaccine was licensed in the US in 1967 and widely used since 1977 in the MMR vaccine. Most provinces include the mumps vaccine (MMR) starting at 12 months, and a second at 18 months.
While the vaccine may have been effective in eliminating mumps in childhood, the protection wanes with age and large scale outbreaks have occurred in vaccinated adolescents and adults.
The mumps vaccine is given in combination with measles and rubella (MMR) and chicken pox (MMR-V). These are all live-viruses.
Individual mumps vaccines are no longer available to consumers.
The risks associated with combination vaccines have not been tested.
Injecting multiple antigens and toxins at once may increase the risk of overwhelming the body’s natural defence mechanisms and detoxification abilities.
The vaccine does not confer life-long immunity, as is evidenced by the need for boosters and the incidence of outbreaks in vaccinated individuals.

Considerations for the Vaccine Decision

Contracting mumps confers life-long immunity, and when experienced in childhood prevents contracting mumps in adolescence and adulthood where the risk of complications is higher.
Japan does not include the mumps vaccine in the recommended schedule and less than 25% of children are vaccinated against mumps.
The mumps vaccine is given in combination with three other live vaccines and may be causing neurological damage in some children. There is compelling evidence that administering the MMR vaccine prior to three years can cause regressive autism. Autism has become epidemic with 1 in 36 children diagnosed.
Thomas Cowan states – “Children who are supported to work through these healing crises are invariably healthier and more resilient than children in whom these inflammatory crises have been suppressed with vaccines, antibiotics, and anti-inflammatory drugs.” [39]
A US HHS study acknowledged that less than 1% of vaccine adverse events are reported.[40]
The safety of the mumps vaccine has not been proven against a true placebo.

For more information: https://www.nvic.org/vaccines-and-diseases/Mumps

References

[38] Minnesota Department of Health. Mumps Clinical Information. June 2016.

[39] Vaccines, Autoimmunity, and the Changing Nature of Childhood Illness – Thomas Cowan, MD, 2018, p. 97

[40] Vaccine Adverse Events Reporting System – https://digital.ahrq.gov/sites/default/files/docs/publication/r18hs017045-lazarus-final-report-2011.pdf

Vaccine Product Monographs

MMR (measles, mumps, rubella)

Product: MMR II (Merck)

Product Monograph: https://www.merck.ca/en/wp-content/uploads/sites/20/2021/04/MMR_II-PM_E.pdf (29 pages)

Patient Information sheet: https://www.merck.ca/en/wp-content/uploads/sites/20/2021/04/MMR_II-CI_E.pdf

Manufacturer website: https://www.merck.ca/en/vaccines-2/

Product: Priorix (GSK)